SynthesisClinical and experimental medicine2025

Risk of new or recurrent cancer during treatment with biologics in patients with immune-mediated inflammatory diseases and previous cancer: a meta-analysis.

Daniel Isufi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.